Literature DB >> 17278262

Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.

Andrew J Davies1, Andreas Rosenwald, George Wright, Abigail Lee, Kim W Last, Dennis D Weisenburger, Wing C Chan, Jan Delabie, Rita M Braziel, Elias Campo, Randy D Gascoyne, Elaine S Jaffe, Konrad Muller-Hermelink, German Ott, Maria Calaminici, Andrew J Norton, Lindsey K Goff, Jude Fitzgibbon, Louis M Staudt, T Andrew Lister.   

Abstract

This study was undertaken to further elucidate the biological mechanisms underlying the frequent event of transformation of follicular lymphoma (FL) to diffuse large B-cell lymphoma (t-FL). The gene expression profiles of 20 paired lymph node biopsies, derived from the same patient pre- and post-transformation, were analysed using the Lymphochip cDNA microarray. TP53 mutation analysis was performed and copy number alterations at the c-REL and CDNK2A examined. Immunohistochemistry was performed on an independent panel of paired transformation paraffin-embedded samples. Transformed follicular lymphoma was predominantly of the germinal centre B-like phenotype both at the mRNA and protein level. Despite this homogeneity, transformation proceeded by at least two pathways. One mechanism was characterised by high proliferation, as assessed by the co-ordinately expressed genes of the proliferation signature. This group was associated with the presence of recurrent oncogenic abnormalities. In the remaining cases, proliferation was not increased and transformation proceeded by alternative routes as yet undetermined. Genes involved in cellular proliferation prevailed amongst those that were significantly increased upon transformation and T cell and follicular dendritic-associated genes predominated amongst those that decreased. t-FL is a germinal centre B (GCB)-like malignancy that evolves by two pathways, one that is similar in proliferation rate to the antecedent FL and the other that has a higher proliferation rate and is characterised by the presence of recognised oncogenic abnormalities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17278262      PMCID: PMC2532951          DOI: 10.1111/j.1365-2141.2006.06439.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  47 in total

1.  Genetic instability is associated with histological transformation of follicle center lymphoma.

Authors:  M Nagy; M Balázs; Z Adám; Z Petkó; B Tímár; Z Szereday; T László; R A Warnke; A Matolcsy
Journal:  Leukemia       Date:  2000-12       Impact factor: 11.528

2.  Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.

Authors:  Z Szereday; B Csernus; M Nagy; T László; R A Warnke; A Matolcsy
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma.

Authors:  C I Chen; M Crump; R Tsang; A K Stewart; A Keating
Journal:  Br J Haematol       Date:  2001-04       Impact factor: 6.998

4.  High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.

Authors:  C D Williams; C N Harrison; T A Lister; A J Norton; A K Blystad; B Coiffier; G Taghipour; N Schmitz; A H Goldstone
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

5.  Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.

Authors:  M Labuhn; G Jones; E J Speel; D Maier; C Zweifel; O Gratzl; E G Van Meir; M E Hegi; A Merlo
Journal:  Oncogene       Date:  2001-03-01       Impact factor: 9.867

6.  Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia.

Authors:  D Capello; U Vitolo; L Pasqualucci; S Quattrone; G Migliaretti; L Fassone; C Ariatti; D Vivenza; A Gloghini; C Pastore; C Lanza; J Nomdedeu; B Botto; R Freilone; D Buonaiuto; V Zagonel; E Gallo; G Palestro; G Saglio; R Dalla-Favera; A Carbone; G Gaidano
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

7.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

8.  Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene.

Authors:  I S Lossos; R Levy
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

9.  The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma.

Authors:  L K Goff; M J Neat; C R Crawley; L Jones; E Jones; T A Lister; R K Gupta
Journal:  Br J Haematol       Date:  2000-11       Impact factor: 6.998

10.  Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma.

Authors:  R E Hough; J R Goepel; H E Alcock; B W Hancock; P C Lorigan; D W Hammond
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

View more
  38 in total

1.  A novel method of amplification of FFPET-derived RNA enables accurate disease classification with microarrays.

Authors:  P Mickey Williams; Rui Li; Nathalie A Johnson; George Wright; Joe-Don Heath; Randy D Gascoyne
Journal:  J Mol Diagn       Date:  2010-08-05       Impact factor: 5.568

2.  Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression.

Authors:  Brygida Bisikirska; Mukesh Bansal; Yao Shen; Julie Teruya-Feldstein; Raju Chaganti; Andrea Califano
Journal:  Cancer Res       Date:  2015-11-20       Impact factor: 12.701

3.  Genetics of follicular lymphoma transformation.

Authors:  Laura Pasqualucci; Hossein Khiabanian; Marco Fangazio; Mansi Vasishtha; Monica Messina; Antony B Holmes; Peter Ouillette; Vladimir Trifonov; Davide Rossi; Fabrizio Tabbò; Maurilio Ponzoni; Amy Chadburn; Vundavalli V Murty; Govind Bhagat; Gianluca Gaidano; Giorgio Inghirami; Sami N Malek; Raul Rabadan; Riccardo Dalla-Favera
Journal:  Cell Rep       Date:  2014-01-02       Impact factor: 9.423

Review 4.  Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach.

Authors:  Nishitha Reddy; Bipin N Savani
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-11       Impact factor: 5.742

Review 5.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

Review 6.  Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.

Authors:  Lesley-Ann Sutton; Richard Rosenquist
Journal:  Haematologica       Date:  2015-01       Impact factor: 9.941

7.  A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.

Authors:  Chloé B Steen; Ellen Leich; June H Myklebust; Sandra Lockmer; Jillian F Wise; Björn E Wahlin; Bjørn Østenstad; Knut Liestøl; Eva Kimby; Andreas Rosenwald; Erlend B Smeland; Harald Holte; Ole Christian Lingjærde; Marianne Brodtkorb
Journal:  Haematologica       Date:  2019-03-07       Impact factor: 9.941

Review 8.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics.

Authors:  Tracy A Brooks; Laurence H Hurley
Journal:  Nat Rev Cancer       Date:  2009-11-12       Impact factor: 60.716

Review 9.  Progress against follicular lymphoma.

Authors:  Jonathan H Schatz; Elisa Oricchio; Soham D Puvvada; H Guido Wendel
Journal:  Curr Opin Hematol       Date:  2013-07       Impact factor: 3.284

10.  Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy.

Authors:  Alan G Ramsay; Andrew J Clear; Gavin Kelly; Rewas Fatah; Janet Matthews; Finlay Macdougall; T Andrew Lister; Abigail M Lee; Maria Calaminici; John G Gribben
Journal:  Blood       Date:  2009-09-28       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.